BJ
IHE icon

Brouwer & Janachowski’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Brouwer & Janachowski’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-45
Closed -$2K – 59
2014
Q1 		$2K Buy
+45
New +$1.89K ﹤0.01% 87

Other funds holding IHE

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
AWA
ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
SFI
SPC Financial Inc Rockville, Maryland $1.28B AUM 12.6% 1-Year Est. Return
U
UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Brouwer & Janachowski's IHE Position: Q2 2014 in Review

Brouwer & Janachowski sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2014, closing a stake of 45 shares — an estimated $2K sold.

Brouwer & Janachowski first reported a position in IHE in Q1 2014 and held it in 1 quarter. The position peaked at $2K in Q1 2014. 87 funds tracked by Wall St. Rank hold IHE as of Q2 2014.

  • Brouwer & Janachowski reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2014 after selling out during the quarter.
  • Brouwer & Janachowski sold 45 iShares US Pharmaceuticals ETF shares in Q2 2014, an estimated $2K.
  • Brouwer & Janachowski first reported a position in iShares US Pharmaceuticals ETF in Q1 2014 and held it in 1 quarter.
  • Brouwer & Janachowski's iShares US Pharmaceuticals ETF position peaked at $2K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2014.

Based on Brouwer & Janachowski's 13F filing for Q2 2014, filed 11 Aug 2014.